您的购物车当前为空
别名 N-(4,6-dimethylpyridin-2-yl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbothioamide
NCT-502 (N-(4,6-dimethylpyridin-2-yl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbothioamide) 是磷酸甘油酸脱氢酶 (PHGDH) 抑制剂(IC50:3.7 μM),对 PHGDH 依赖性癌细胞具有细胞毒性,能够减少葡萄糖衍生的丝氨酸的产生,。


为众多的药物研发团队赋能,
让新药发现更简单!
NCT-502 (N-(4,6-dimethylpyridin-2-yl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbothioamide) 是磷酸甘油酸脱氢酶 (PHGDH) 抑制剂(IC50:3.7 μM),对 PHGDH 依赖性癌细胞具有细胞毒性,能够减少葡萄糖衍生的丝氨酸的产生,。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 283 | 现货 | |
| 2 mg | ¥ 395 | 现货 | |
| 5 mg | ¥ 652 | 现货 | |
| 10 mg | ¥ 947 | 现货 | |
| 25 mg | ¥ 1,980 | 现货 | |
| 50 mg | ¥ 3,490 | 现货 | |
| 100 mg | ¥ 5,130 | 现货 | |
| 500 mg | ¥ 10,800 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 721 | 现货 |
NCT-502 相关产品
| 产品描述 | NCT-502 (N-(4,6-dimethylpyridin-2-yl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbothioamide) is a human phosphoglycerate dehydrogenase inhibitor, cytotoxic to PHGDH-dependent cancer cells. It decreases glucose-derived serine production and it has an IC50 of 3.7 μM against PHGDH. |
| 靶点活性 | PHGDH:3.7 μM |
| 体外活性 | NCT-502 对MDA-MB-468细胞具有细胞毒性(EC50为15.2 μM)[1]。 |
| 别名 | N-(4,6-dimethylpyridin-2-yl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbothioamide |
| 分子量 | 395.45 |
| 分子式 | C18H20F3N5S |
| CAS No. | 1542213-00-2 |
| Smiles | Cc1cc(C)nc(NC(=S)N2CCN(CC2)c2ccc(cn2)C(F)(F)F)c1 |
| 密度 | 1.355 g/cm3 (Predicted) |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: < 0.1 mg/mL (insoluble) DMSO: 55 mg/mL (139.08 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.06 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容